

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.09589001 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.95555566 |
| 3 | sodium ion export (GO:0071436) | 5.58269514 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.51889879 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.96150863 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.94404639 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.94216801 |
| 8 | glutamate secretion (GO:0014047) | 4.83785482 |
| 9 | cellular potassium ion homeostasis (GO:0030007) | 4.78577786 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.78419609 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.53955106 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.51485040 |
| 13 | regulation of ARF protein signal transduction (GO:0032012) | 4.48896709 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.33555929 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.32758423 |
| 16 | vocalization behavior (GO:0071625) | 4.31602347 |
| 17 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.26607997 |
| 18 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.15813950 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.14493751 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.14493751 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.12053344 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.06541593 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.01672887 |
| 24 | neurotransmitter secretion (GO:0007269) | 3.96292738 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.90143029 |
| 26 | exploration behavior (GO:0035640) | 3.89729090 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89501434 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88203495 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.83754001 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 3.82664133 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.80304190 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.76873732 |
| 33 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.71875626 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68073302 |
| 35 | long-term memory (GO:0007616) | 3.67560044 |
| 36 | proline transport (GO:0015824) | 3.64177498 |
| 37 | leukocyte aggregation (GO:0070486) | 3.63867048 |
| 38 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.61280158 |
| 39 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.60989502 |
| 40 | regulation of ARF GTPase activity (GO:0032312) | 3.60903958 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 3.60279009 |
| 42 | regulation of synapse structural plasticity (GO:0051823) | 3.59096083 |
| 43 | potassium ion import (GO:0010107) | 3.58998868 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.58936160 |
| 45 | thymic T cell selection (GO:0045061) | 3.53309231 |
| 46 | neuromuscular process controlling balance (GO:0050885) | 3.51109971 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.50385849 |
| 48 | glutamate receptor signaling pathway (GO:0007215) | 3.49463585 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.47087081 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.42664068 |
| 51 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.42304345 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39437522 |
| 53 | membrane depolarization during action potential (GO:0086010) | 3.36784266 |
| 54 | cell communication by electrical coupling (GO:0010644) | 3.36646817 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34102476 |
| 56 | cellular sodium ion homeostasis (GO:0006883) | 3.33478258 |
| 57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.33127321 |
| 58 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.29689948 |
| 59 | mannose metabolic process (GO:0006013) | 3.27995547 |
| 60 | protein localization to synapse (GO:0035418) | 3.25403204 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21038116 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.20232343 |
| 63 | signal complex assembly (GO:0007172) | 3.19665441 |
| 64 | regulation of regulated secretory pathway (GO:1903305) | 3.17947652 |
| 65 | T cell selection (GO:0045058) | 3.16804305 |
| 66 | detection of bacterium (GO:0016045) | 3.14172030 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13826042 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13826042 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 3.13826042 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13826042 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.13826042 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13826042 |
| 73 | positive regulation of membrane potential (GO:0045838) | 3.13519983 |
| 74 | detection of other organism (GO:0098543) | 3.10049945 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 3.07987592 |
| 76 | positive T cell selection (GO:0043368) | 3.07934000 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.07492691 |
| 78 | regulation of synaptic plasticity (GO:0048167) | 3.06189919 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.03002034 |
| 80 | response to muramyl dipeptide (GO:0032495) | 3.02380677 |
| 81 | neuron-neuron synaptic transmission (GO:0007270) | 3.01042670 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 3.00666224 |
| 83 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00580458 |
| 84 | L-amino acid import (GO:0043092) | 2.98409641 |
| 85 | neuromuscular process controlling posture (GO:0050884) | 2.97839673 |
| 86 | dendritic spine morphogenesis (GO:0060997) | 2.97541445 |
| 87 | glycine transport (GO:0015816) | 2.95735606 |
| 88 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.95174346 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93741243 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 2.93443405 |
| 91 | positive regulation of fibroblast migration (GO:0010763) | 2.90723425 |
| 92 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90671729 |
| 93 | regulation of neurotransmitter secretion (GO:0046928) | 2.89874149 |
| 94 | membrane depolarization (GO:0051899) | 2.89648099 |
| 95 | positive regulation of Rap GTPase activity (GO:0032854) | 2.89613474 |
| 96 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.89530082 |
| 97 | neurotransmitter transport (GO:0006836) | 2.89516356 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.87982420 |
| 99 | establishment of nucleus localization (GO:0040023) | 2.86677836 |
| 100 | regulation of Rap GTPase activity (GO:0032317) | 2.86071282 |
| 101 | positive regulation of protein dephosphorylation (GO:0035307) | 2.85824830 |
| 102 | cell differentiation in hindbrain (GO:0021533) | 2.85678323 |
| 103 | response to peptidoglycan (GO:0032494) | 2.83160923 |
| 104 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81976185 |
| 105 | neutrophil activation involved in immune response (GO:0002283) | 2.80926607 |
| 106 | vesicle transport along microtubule (GO:0047496) | 2.80573145 |
| 107 | regulation of neurotransmitter levels (GO:0001505) | 2.79583297 |
| 108 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.78221997 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77857271 |
| 110 | amino acid import (GO:0043090) | 2.76909106 |
| 111 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.76327188 |
| 112 | membrane repolarization (GO:0086009) | 2.74495380 |
| 113 | clathrin coat assembly (GO:0048268) | 2.73814509 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 2.73191074 |
| 115 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.72811106 |
| 116 | nerve growth factor signaling pathway (GO:0038180) | 2.71252323 |
| 117 | potassium ion homeostasis (GO:0055075) | 2.70178622 |
| 118 | actin filament capping (GO:0051693) | 2.69430381 |
| 119 | chemosensory behavior (GO:0007635) | 2.69256393 |
| 120 | long-term synaptic potentiation (GO:0060291) | 2.68963112 |
| 121 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.67990725 |
| 122 | cellular extravasation (GO:0045123) | 2.67603809 |
| 123 | response to interleukin-15 (GO:0070672) | 2.67468568 |
| 124 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65199559 |
| 125 | germinal center formation (GO:0002467) | 2.63964147 |
| 126 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63638157 |
| 127 | alanine transport (GO:0032328) | 2.62383267 |
| 128 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61861788 |
| 129 | prepulse inhibition (GO:0060134) | 2.61415191 |
| 130 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.61039011 |
| 131 | regulation of defense response to virus by virus (GO:0050690) | 2.57603214 |
| 132 | regulation of neurotransmitter transport (GO:0051588) | 2.56206928 |
| 133 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54542191 |
| 134 | regulation of beta-amyloid formation (GO:1902003) | 2.54369292 |
| 135 | dendrite morphogenesis (GO:0048813) | 2.53851641 |
| 136 | mast cell degranulation (GO:0043303) | 2.53653847 |
| 137 | mast cell activation involved in immune response (GO:0002279) | 2.53653847 |
| 138 | negative thymic T cell selection (GO:0045060) | 2.53100897 |
| 139 | negative T cell selection (GO:0043383) | 2.52308456 |
| 140 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.52131225 |
| 141 | neuromuscular process (GO:0050905) | 2.52042395 |
| 142 | positive regulation of B cell differentiation (GO:0045579) | 2.50807791 |
| 143 | actin filament polymerization (GO:0030041) | 2.49818388 |
| 144 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.49535914 |
| 145 | cell communication involved in cardiac conduction (GO:0086065) | 2.49099092 |
| 146 | regulation of synapse maturation (GO:0090128) | 2.44963511 |
| 147 | protein localization to endosome (GO:0036010) | 2.42949331 |
| 148 | positive regulation of regulated secretory pathway (GO:1903307) | 2.42316654 |
| 149 | negative regulation of type 2 immune response (GO:0002829) | 2.42213509 |
| 150 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.40184184 |
| 151 | Peyers patch development (GO:0048541) | 2.39049337 |
| 152 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.39049337 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 2.38551591 |
| 154 | activation of JUN kinase activity (GO:0007257) | 2.38493806 |
| 155 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35944847 |
| 156 | adenosine receptor signaling pathway (GO:0001973) | 2.31718636 |
| 157 | regulation of B cell differentiation (GO:0045577) | 2.31083999 |
| 158 | activation of Rac GTPase activity (GO:0032863) | 2.28930229 |
| 159 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.28923979 |
| 160 | modulation by virus of host process (GO:0019054) | 2.27082470 |
| 161 | detection of external biotic stimulus (GO:0098581) | 2.26474140 |
| 162 | T cell migration (GO:0072678) | 2.25131170 |
| 163 | negative regulation of phagocytosis (GO:0050765) | 2.24994286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82070372 |
| 2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.22275688 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.08182635 |
| 4 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.96816537 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.94714431 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78685956 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.71137234 |
| 8 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.61029236 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.51399940 |
| 10 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.41719315 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.28980050 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.19535921 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15978201 |
| 14 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.13030232 |
| 15 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.08314009 |
| 16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01188044 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.99980577 |
| 18 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.97489024 |
| 19 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.96144320 |
| 20 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.96109889 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94791043 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94744014 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93738660 |
| 24 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.92773106 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90746428 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89798459 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.88466630 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86195452 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86195452 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.85531536 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82030929 |
| 32 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.81842216 |
| 33 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78911449 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77961905 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76797952 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.76385228 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75517240 |
| 38 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74296496 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.68741959 |
| 40 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.64764689 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64037945 |
| 42 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.62946353 |
| 43 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.62829742 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.59810094 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59804819 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59186245 |
| 47 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53080057 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51447605 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49677917 |
| 50 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48215001 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47031979 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.46998172 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.46845089 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46421162 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43392211 |
| 56 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.42304972 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41598274 |
| 58 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41043703 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40612915 |
| 60 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38973979 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38330459 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.38049749 |
| 63 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36962041 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35664855 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33697718 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32527754 |
| 67 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.32041462 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31731015 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30725940 |
| 70 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28586275 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.28321829 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27598540 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27351881 |
| 74 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26800472 |
| 75 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.26252195 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25418067 |
| 77 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23000286 |
| 78 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21615167 |
| 79 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20645917 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20483343 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19702163 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19059122 |
| 83 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18422064 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18358894 |
| 85 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18337548 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17256717 |
| 87 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16961291 |
| 88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14025719 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13860290 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13847144 |
| 91 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11897108 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.11372467 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11220706 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10824679 |
| 95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09461066 |
| 96 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.08980652 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07195480 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06445404 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06341024 |
| 100 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06010285 |
| 101 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05339944 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05293701 |
| 103 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04466200 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04108027 |
| 105 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03807931 |
| 106 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03366058 |
| 107 | AR_19668381_ChIP-Seq_PC3_Human | 1.03261674 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 1.02781101 |
| 109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02289669 |
| 110 | MYB_26560356_Chip-Seq_TH2_Human | 1.02184948 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02112907 |
| 112 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02055325 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00812637 |
| 114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99621700 |
| 115 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99135442 |
| 116 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98945607 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98471023 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98249504 |
| 119 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98214214 |
| 120 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97731765 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97324781 |
| 122 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97069459 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96710888 |
| 124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96454917 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96450271 |
| 126 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96080288 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94515946 |
| 128 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92613792 |
| 129 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92457198 |
| 130 | MAF_26560356_Chip-Seq_TH2_Human | 0.90871883 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89823155 |
| 132 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89395078 |
| 133 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88808547 |
| 134 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88717065 |
| 135 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87357388 |
| 136 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86928946 |
| 137 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.86716028 |
| 138 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86615473 |
| 139 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85296138 |
| 140 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84950444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.30101223 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.85531605 |
| 3 | MP0003436_decreased_susceptibility_to | 3.25812097 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.14567889 |
| 5 | MP0004270_analgesia | 3.08221532 |
| 6 | MP0009046_muscle_twitch | 3.06712840 |
| 7 | MP0008569_lethality_at_weaning | 2.87424357 |
| 8 | MP0009745_abnormal_behavioral_response | 2.86258364 |
| 9 | MP0002064_seizures | 2.82638823 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.80335056 |
| 11 | MP0002736_abnormal_nociception_after | 2.60876081 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.59471357 |
| 13 | MP0003880_abnormal_central_pattern | 2.47394581 |
| 14 | MP0004510_myositis | 2.40161212 |
| 15 | MP0004858_abnormal_nervous_system | 2.29995954 |
| 16 | MP0002272_abnormal_nervous_system | 2.23350397 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.21263531 |
| 18 | MP0008260_abnormal_autophagy | 2.15871525 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.15562456 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.12285509 |
| 21 | MP0003724_increased_susceptibility_to | 2.07828971 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.02214310 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.01891014 |
| 24 | MP0003329_amyloid_beta_deposits | 2.01608494 |
| 25 | MP0002419_abnormal_innate_immunity | 1.97402696 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.90462832 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.90321024 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.90223386 |
| 29 | * MP0005000_abnormal_immune_tolerance | 1.89016716 |
| 30 | * MP0005025_abnormal_response_to | 1.87409153 |
| 31 | MP0002822_catalepsy | 1.86824536 |
| 32 | MP0001970_abnormal_pain_threshold | 1.83370089 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.83154602 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.82389604 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.80970103 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.77454742 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.77351626 |
| 38 | MP0005451_abnormal_body_composition | 1.74084154 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.73564249 |
| 40 | MP0001486_abnormal_startle_reflex | 1.69700130 |
| 41 | MP0005387_immune_system_phenotype | 1.64285629 |
| 42 | MP0001790_abnormal_immune_system | 1.64285629 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.62363324 |
| 44 | MP0003303_peritoneal_inflammation | 1.61761375 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.61355112 |
| 46 | * MP0002723_abnormal_immune_serum | 1.60624458 |
| 47 | MP0003633_abnormal_nervous_system | 1.59673159 |
| 48 | MP0003879_abnormal_hair_cell | 1.56848306 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.55189402 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.49036154 |
| 51 | MP0003075_altered_response_to | 1.47561365 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.42947750 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.41969970 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.41179732 |
| 55 | MP0006082_CNS_inflammation | 1.39356054 |
| 56 | MP0000604_amyloidosis | 1.38294100 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.33357161 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.33061224 |
| 59 | MP0002184_abnormal_innervation | 1.32929661 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.32105351 |
| 61 | MP0008874_decreased_physiological_sensi | 1.29428939 |
| 62 | MP0004885_abnormal_endolymph | 1.27044186 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.25971264 |
| 64 | MP0004924_abnormal_behavior | 1.25971264 |
| 65 | MP0003631_nervous_system_phenotype | 1.25757820 |
| 66 | MP0001851_eye_inflammation | 1.24767435 |
| 67 | MP0000955_abnormal_spinal_cord | 1.23779476 |
| 68 | MP0003787_abnormal_imprinting | 1.21363439 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 1.19600331 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.19360412 |
| 71 | MP0004381_abnormal_hair_follicle | 1.19249369 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 1.17957058 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.17147734 |
| 74 | MP0005409_darkened_coat_color | 1.17044137 |
| 75 | MP0003866_abnormal_defecation | 1.16273986 |
| 76 | MP0003045_fibrosis | 1.14665149 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.10527782 |
| 78 | MP0001849_ear_inflammation | 1.10408639 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.08629986 |
| 80 | MP0002405_respiratory_system_inflammati | 1.08594560 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 1.07823828 |
| 82 | MP0009785_altered_susceptibility_to | 1.07752143 |
| 83 | MP0008872_abnormal_physiological_respon | 1.07506602 |
| 84 | MP0003828_pulmonary_edema | 1.04869201 |
| 85 | * MP0002429_abnormal_blood_cell | 1.04820965 |
| 86 | MP0004130_abnormal_muscle_cell | 1.04472786 |
| 87 | MP0003690_abnormal_glial_cell | 1.02248252 |
| 88 | MP0000751_myopathy | 0.99935618 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.97495137 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.96654559 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.96312630 |
| 92 | MP0000858_altered_metastatic_potential | 0.95439735 |
| 93 | MP0002882_abnormal_neuron_morphology | 0.94363745 |
| 94 | MP0009278_abnormal_bone_marrow | 0.93166236 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.92687120 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.92556806 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.92055701 |
| 98 | MP0000920_abnormal_myelination | 0.91111953 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.90182362 |
| 100 | MP0005166_decreased_susceptibility_to | 0.89878860 |
| 101 | MP0003632_abnormal_nervous_system | 0.89841008 |
| 102 | MP0004484_altered_response_of | 0.89726777 |
| 103 | MP0009840_abnormal_foam_cell | 0.88206406 |
| 104 | MP0000747_muscle_weakness | 0.86934046 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.84567730 |
| 106 | MP0005310_abnormal_salivary_gland | 0.82925673 |
| 107 | MP0005671_abnormal_response_to | 0.80703257 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.78518082 |
| 109 | * MP0002398_abnormal_bone_marrow | 0.77794415 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.77595590 |
| 111 | MP0002152_abnormal_brain_morphology | 0.76536753 |
| 112 | MP0003091_abnormal_cell_migration | 0.76049044 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.75135920 |
| 114 | MP0004147_increased_porphyrin_level | 0.74733121 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.74039473 |
| 116 | MP0005535_abnormal_body_temperature | 0.73893202 |
| 117 | MP0001502_abnormal_circadian_rhythm | 0.72045448 |
| 118 | MP0003123_paternal_imprinting | 0.71665277 |
| 119 | MP0008770_decreased_survivor_rate | 0.71648011 |
| 120 | MP0002229_neurodegeneration | 0.70704602 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.70596444 |
| 122 | MP0002933_joint_inflammation | 0.70314719 |
| 123 | MP0001873_stomach_inflammation | 0.67643306 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.66383980 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.66078828 |
| 126 | MP0004142_abnormal_muscle_tone | 0.65812306 |
| 127 | MP0000685_abnormal_immune_system | 0.65112918 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.62817802 |
| 129 | MP0001800_abnormal_humoral_immune | 0.62506353 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.60979602 |
| 131 | MP0005397_hematopoietic_system_phenotyp | 0.60979602 |
| 132 | * MP0002420_abnormal_adaptive_immunity | 0.60573994 |
| 133 | MP0003634_abnormal_glial_cell | 0.59872312 |
| 134 | MP0000778_abnormal_nervous_system | 0.59314588 |
| 135 | MP0004085_abnormal_heartbeat | 0.59154812 |
| 136 | * MP0001819_abnormal_immune_cell | 0.59063636 |
| 137 | MP0002396_abnormal_hematopoietic_system | 0.57641528 |
| 138 | MP0002083_premature_death | 0.56652320 |
| 139 | MP0002166_altered_tumor_susceptibility | 0.55405025 |
| 140 | MP0004947_skin_inflammation | 0.55063211 |
| 141 | * MP0000716_abnormal_immune_system | 0.54774788 |
| 142 | MP0002722_abnormal_immune_system | 0.54242652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.41802903 |
| 2 | Focal motor seizures (HP:0011153) | 4.91670628 |
| 3 | Visual hallucinations (HP:0002367) | 4.84282396 |
| 4 | Focal seizures (HP:0007359) | 4.82067899 |
| 5 | Action tremor (HP:0002345) | 4.61113387 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.37848459 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.94601691 |
| 8 | Dysmetric saccades (HP:0000641) | 3.82614536 |
| 9 | Febrile seizures (HP:0002373) | 3.66330325 |
| 10 | Hemiplegia (HP:0002301) | 3.56143807 |
| 11 | Annular pancreas (HP:0001734) | 3.52142217 |
| 12 | Atonic seizures (HP:0010819) | 3.48980165 |
| 13 | Impaired smooth pursuit (HP:0007772) | 3.46965911 |
| 14 | Abnormality of the lower motor neuron (HP:0002366) | 3.41407012 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.37540941 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.29246451 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.20261798 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.19339131 |
| 19 | Diplopia (HP:0000651) | 3.18693019 |
| 20 | Abnormality of binocular vision (HP:0011514) | 3.18693019 |
| 21 | Poor eye contact (HP:0000817) | 3.15786351 |
| 22 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.12869459 |
| 23 | Abnormal social behavior (HP:0012433) | 3.12657627 |
| 24 | Impaired social interactions (HP:0000735) | 3.12657627 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 3.10110816 |
| 26 | Absence seizures (HP:0002121) | 3.05967379 |
| 27 | Depression (HP:0000716) | 3.00660036 |
| 28 | Truncal ataxia (HP:0002078) | 2.99688830 |
| 29 | Cellulitis (HP:0100658) | 2.99269372 |
| 30 | Pointed chin (HP:0000307) | 2.95873780 |
| 31 | Dysmetria (HP:0001310) | 2.94654967 |
| 32 | Hyperacusis (HP:0010780) | 2.94523253 |
| 33 | Abnormality of macrophages (HP:0004311) | 2.92791806 |
| 34 | Papilledema (HP:0001085) | 2.91638421 |
| 35 | Myositis (HP:0100614) | 2.86923243 |
| 36 | Bundle branch block (HP:0011710) | 2.86734817 |
| 37 | Insomnia (HP:0100785) | 2.86391694 |
| 38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.85593230 |
| 39 | Ventricular fibrillation (HP:0001663) | 2.84303160 |
| 40 | Postural instability (HP:0002172) | 2.83303258 |
| 41 | Slow saccadic eye movements (HP:0000514) | 2.79132047 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.78932434 |
| 43 | Generalized tonic-clonic seizures (HP:0002069) | 2.78755249 |
| 44 | Increased IgE level (HP:0003212) | 2.76868455 |
| 45 | Genetic anticipation (HP:0003743) | 2.76771396 |
| 46 | Urinary urgency (HP:0000012) | 2.70463500 |
| 47 | Dialeptic seizures (HP:0011146) | 2.68860393 |
| 48 | Scanning speech (HP:0002168) | 2.67832047 |
| 49 | Ankle clonus (HP:0011448) | 2.66510399 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.63952951 |
| 51 | Intention tremor (HP:0002080) | 2.63837124 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59920679 |
| 53 | Obstructive lung disease (HP:0006536) | 2.59920679 |
| 54 | Spinal canal stenosis (HP:0003416) | 2.55921857 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.52926707 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.51120930 |
| 57 | Meningitis (HP:0001287) | 2.50537549 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50248928 |
| 59 | Status epilepticus (HP:0002133) | 2.48018320 |
| 60 | Broad-based gait (HP:0002136) | 2.46839621 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.46410974 |
| 62 | Lower limb asymmetry (HP:0100559) | 2.39802494 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 2.35907886 |
| 64 | Polygenic inheritance (HP:0010982) | 2.35574169 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.34726372 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.34589387 |
| 67 | Macroorchidism (HP:0000053) | 2.34379459 |
| 68 | Stereotypic behavior (HP:0000733) | 2.32318379 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.31529519 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.30562803 |
| 71 | Gingivitis (HP:0000230) | 2.29704130 |
| 72 | Abnormality of saccadic eye movements (HP:0000570) | 2.28624285 |
| 73 | Hemiparesis (HP:0001269) | 2.28557772 |
| 74 | Colitis (HP:0002583) | 2.27097846 |
| 75 | Orchitis (HP:0100796) | 2.23863959 |
| 76 | Pustule (HP:0200039) | 2.23730317 |
| 77 | Distal lower limb amyotrophy (HP:0008944) | 2.21840510 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21409614 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20755635 |
| 80 | Mutism (HP:0002300) | 2.17934993 |
| 81 | Spastic gait (HP:0002064) | 2.17401855 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17008578 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.16043027 |
| 84 | Cerebral aneurysm (HP:0004944) | 2.15727554 |
| 85 | Stomatitis (HP:0010280) | 2.11722511 |
| 86 | Peripheral hypomyelination (HP:0007182) | 2.11100391 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 2.10929161 |
| 88 | Recurrent skin infections (HP:0001581) | 2.10601733 |
| 89 | Bradykinesia (HP:0002067) | 2.09600858 |
| 90 | Chest pain (HP:0100749) | 2.07158996 |
| 91 | Rapidly progressive (HP:0003678) | 2.05177515 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04488110 |
| 93 | Abnormal eating behavior (HP:0100738) | 2.03910601 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.03589216 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.03235363 |
| 96 | Elfin facies (HP:0004428) | 2.01490221 |
| 97 | Impaired vibratory sensation (HP:0002495) | 2.01450884 |
| 98 | Distal upper limb amyotrophy (HP:0007149) | 2.00750191 |
| 99 | Upper limb amyotrophy (HP:0009129) | 2.00750191 |
| 100 | Amyloidosis (HP:0011034) | 2.00200039 |
| 101 | Anxiety (HP:0000739) | 2.00092437 |
| 102 | Apathy (HP:0000741) | 1.98783385 |
| 103 | Recurrent viral infections (HP:0004429) | 1.97834909 |
| 104 | Ocular albinism (HP:0001107) | 1.96527213 |
| 105 | Resting tremor (HP:0002322) | 1.95983046 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95427721 |
| 107 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95427721 |
| 108 | Insidious onset (HP:0003587) | 1.95325405 |
| 109 | Termporal pattern (HP:0011008) | 1.95325405 |
| 110 | Distal lower limb muscle weakness (HP:0009053) | 1.94915442 |
| 111 | Postural tremor (HP:0002174) | 1.94654011 |
| 112 | Broad face (HP:0000283) | 1.93944569 |
| 113 | Epistaxis (HP:0000421) | 1.92912823 |
| 114 | Achilles tendon contracture (HP:0001771) | 1.92911915 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.90919459 |
| 116 | Limb ataxia (HP:0002070) | 1.89626581 |
| 117 | Hand muscle atrophy (HP:0009130) | 1.87619240 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 1.86423643 |
| 119 | Optic neuritis (HP:0100653) | 1.86423643 |
| 120 | Global brain atrophy (HP:0002283) | 1.85825979 |
| 121 | Psychosis (HP:0000709) | 1.83238317 |
| 122 | Vertebral arch anomaly (HP:0008438) | 1.82621374 |
| 123 | Abnormality of the periventricular white matter (HP:0002518) | 1.82527283 |
| 124 | Exercise-induced myalgia (HP:0003738) | 1.82522805 |
| 125 | Deep palmar crease (HP:0006191) | 1.80962219 |
| 126 | Encephalitis (HP:0002383) | 1.80641112 |
| 127 | Gait ataxia (HP:0002066) | 1.80172778 |
| 128 | Neoplasm of the heart (HP:0100544) | 1.79447989 |
| 129 | Hypercortisolism (HP:0001578) | 1.79444348 |
| 130 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79017161 |
| 131 | Hypochromic anemia (HP:0001931) | 1.78929664 |
| 132 | Tetraplegia (HP:0002445) | 1.78294138 |
| 133 | Difficulty running (HP:0009046) | 1.77591926 |
| 134 | Amblyopia (HP:0000646) | 1.77553885 |
| 135 | Diminished motivation (HP:0000745) | 1.77513426 |
| 136 | Vasculitis (HP:0002633) | 1.76771534 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75978890 |
| 138 | Rigidity (HP:0002063) | 1.74380807 |
| 139 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73782563 |
| 140 | Iris hypopigmentation (HP:0007730) | 1.73552638 |
| 141 | Increased cerebral lipofuscin (HP:0011813) | 1.73464586 |
| 142 | Loss of speech (HP:0002371) | 1.73433386 |
| 143 | Easy fatigability (HP:0003388) | 1.73007216 |
| 144 | Obstructive sleep apnea (HP:0002870) | 1.72386897 |
| 145 | Abnormality of the fingertips (HP:0001211) | 1.72352016 |
| 146 | Verrucae (HP:0200043) | 1.72120707 |
| 147 | Papilloma (HP:0012740) | 1.72120707 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.70102046 |
| 149 | Myotonia (HP:0002486) | 1.68219235 |
| 150 | Clonus (HP:0002169) | 1.65823530 |
| 151 | Cerebral inclusion bodies (HP:0100314) | 1.64455611 |
| 152 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.63200633 |
| 153 | Chronic otitis media (HP:0000389) | 1.63106729 |
| 154 | Overriding aorta (HP:0002623) | 1.62714226 |
| 155 | Panhypogammaglobulinemia (HP:0003139) | 1.62530926 |
| 156 | Heterotopia (HP:0002282) | 1.62330155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.71127678 |
| 2 | NTRK3 | 3.13101379 |
| 3 | DAPK2 | 2.77219961 |
| 4 | RIPK4 | 2.74771526 |
| 5 | KSR2 | 2.56168347 |
| 6 | CAMKK1 | 2.50793643 |
| 7 | TRIB3 | 2.47657033 |
| 8 | ERN1 | 2.37037766 |
| 9 | SIK2 | 2.29992817 |
| 10 | EPHA4 | 2.15854998 |
| 11 | PAK6 | 2.11575767 |
| 12 | PRKD3 | 2.07102718 |
| 13 | RIPK1 | 2.04123612 |
| 14 | MINK1 | 1.97629921 |
| 15 | PKN2 | 1.97252222 |
| 16 | EEF2K | 1.96521803 |
| 17 | SMG1 | 1.94505354 |
| 18 | MAP2K3 | 1.76842251 |
| 19 | MAP3K13 | 1.75582428 |
| 20 | SIK1 | 1.75078886 |
| 21 | MAP4K1 | 1.71173234 |
| 22 | MAP3K11 | 1.69098411 |
| 23 | FES | 1.67073017 |
| 24 | TAOK1 | 1.65062945 |
| 25 | ALK | 1.63534877 |
| 26 | CAMKK2 | 1.62959762 |
| 27 | MAP3K4 | 1.61000229 |
| 28 | DAPK1 | 1.58920038 |
| 29 | STK38 | 1.54298274 |
| 30 | PRKCH | 1.54035233 |
| 31 | MAP3K7 | 1.47324989 |
| 32 | RET | 1.38908308 |
| 33 | TYRO3 | 1.37846822 |
| 34 | NTRK1 | 1.37391386 |
| 35 | NTRK2 | 1.33048212 |
| 36 | MAP3K2 | 1.28091684 |
| 37 | PDK1 | 1.27531803 |
| 38 | MAP2K4 | 1.22527589 |
| 39 | CDK5 | 1.21450898 |
| 40 | LMTK2 | 1.21031719 |
| 41 | CAMK1 | 1.16945166 |
| 42 | SGK3 | 1.14892396 |
| 43 | IRAK4 | 1.13031411 |
| 44 | CDK12 | 1.10443077 |
| 45 | BLK | 1.08473737 |
| 46 | GRK6 | 1.07064410 |
| 47 | BTK | 1.05560147 |
| 48 | STK11 | 1.04512120 |
| 49 | CDK19 | 1.04442432 |
| 50 | TAOK2 | 1.03830255 |
| 51 | CAMK1G | 1.03519817 |
| 52 | PTK6 | 1.02589339 |
| 53 | SIK3 | 1.01318653 |
| 54 | ARAF | 1.00607393 |
| 55 | MAP3K10 | 1.00157630 |
| 56 | CSK | 0.98373826 |
| 57 | MARK2 | 0.96761408 |
| 58 | PRPF4B | 0.95881092 |
| 59 | SCYL2 | 0.93533892 |
| 60 | PDPK1 | 0.93441889 |
| 61 | TNK2 | 0.88703215 |
| 62 | KSR1 | 0.88328342 |
| 63 | MAP3K1 | 0.86995274 |
| 64 | TBK1 | 0.85266660 |
| 65 | CAMK4 | 0.83963885 |
| 66 | JAK1 | 0.81413716 |
| 67 | GRK5 | 0.78514065 |
| 68 | PTK2B | 0.77398635 |
| 69 | JAK2 | 0.77244541 |
| 70 | SYK | 0.75823528 |
| 71 | MAP3K3 | 0.75484170 |
| 72 | DMPK | 0.75324502 |
| 73 | RAF1 | 0.75304408 |
| 74 | HCK | 0.75079301 |
| 75 | PRKCG | 0.74426129 |
| 76 | IRAK2 | 0.73009595 |
| 77 | UHMK1 | 0.71430579 |
| 78 | WNK1 | 0.71345093 |
| 79 | JAK3 | 0.70619665 |
| 80 | TESK2 | 0.70053002 |
| 81 | MAP3K14 | 0.69192344 |
| 82 | MAP2K7 | 0.68662628 |
| 83 | SGK2 | 0.68422659 |
| 84 | MAP3K12 | 0.65234132 |
| 85 | PRKG2 | 0.64538413 |
| 86 | ITK | 0.63036565 |
| 87 | FYN | 0.62737589 |
| 88 | MAPK7 | 0.62073386 |
| 89 | RPS6KA2 | 0.60172740 |
| 90 | ZAP70 | 0.59813888 |
| 91 | NEK6 | 0.59667951 |
| 92 | CDK15 | 0.59252212 |
| 93 | FGFR3 | 0.59034525 |
| 94 | CDC42BPA | 0.59018405 |
| 95 | TESK1 | 0.58667845 |
| 96 | MARK1 | 0.57800368 |
| 97 | MAP2K2 | 0.57753259 |
| 98 | MAPK12 | 0.56684264 |
| 99 | BMX | 0.54927480 |
| 100 | IRAK3 | 0.54628077 |
| 101 | SGK494 | 0.54419063 |
| 102 | SGK223 | 0.54419063 |
| 103 | CDK18 | 0.54298101 |
| 104 | SGK1 | 0.54014043 |
| 105 | CDK11A | 0.53716192 |
| 106 | IKBKE | 0.53524724 |
| 107 | HIPK2 | 0.52464857 |
| 108 | CSF1R | 0.50010760 |
| 109 | RPS6KC1 | 0.49897326 |
| 110 | RPS6KL1 | 0.49897326 |
| 111 | EPHB1 | 0.49824720 |
| 112 | MAP2K6 | 0.49620586 |
| 113 | MAPK11 | 0.48504708 |
| 114 | RPS6KA3 | 0.47364087 |
| 115 | MAPK4 | 0.46669764 |
| 116 | CDK14 | 0.46553546 |
| 117 | BMPR2 | 0.45742820 |
| 118 | ICK | 0.45306598 |
| 119 | PTK2 | 0.45125527 |
| 120 | TYK2 | 0.45021124 |
| 121 | LCK | 0.44314417 |
| 122 | PDGFRB | 0.43891655 |
| 123 | PRKD2 | 0.43322852 |
| 124 | DAPK3 | 0.43287839 |
| 125 | TXK | 0.42930170 |
| 126 | PHKG2 | 0.42855817 |
| 127 | PHKG1 | 0.42855817 |
| 128 | LYN | 0.42507437 |
| 129 | PINK1 | 0.42347461 |
| 130 | MAP3K6 | 0.41916033 |
| 131 | SRC | 0.40915461 |
| 132 | PDGFRA | 0.40686070 |
| 133 | MAPK10 | 0.40300020 |
| 134 | FGFR4 | 0.40251162 |
| 135 | TTN | 0.39197533 |
| 136 | CAMK1D | 0.38693903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Long-term potentiation_Homo sapiens_hsa04720 | 2.54396528 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.44158335 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.33092052 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27321913 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.14707054 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13741564 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10888090 |
| 8 | Salivary secretion_Homo sapiens_hsa04970 | 2.04798129 |
| 9 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93182934 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.91783607 |
| 11 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85519623 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.83311074 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72521074 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.71910710 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.70876924 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66013331 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.60055518 |
| 18 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.59578073 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59194870 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.58459894 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56829214 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.56583263 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55842901 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55666092 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.48875041 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41859144 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41740257 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40941457 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.40557470 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37992188 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.37803129 |
| 32 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.30542961 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30114754 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.25057826 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24659034 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24464871 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24410227 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22840817 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.20042667 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18877417 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13004618 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11986563 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11666603 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.09679845 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07957772 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07934575 |
| 47 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07642760 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06254678 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05338036 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04375427 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03406948 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02591504 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01224655 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00597573 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99098719 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94559575 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93121849 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.90696462 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89778779 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88715766 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86122662 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85439256 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84661234 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83959275 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.82716303 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81104809 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80835695 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79489255 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78917420 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78789487 |
| 71 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77517975 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.76853770 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76316378 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75774937 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.75519736 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74873275 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.74247032 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73717037 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73224912 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72413995 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72333739 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72200989 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71681482 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71527951 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71282289 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71189756 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70924401 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.70696490 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70292216 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70031266 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68416346 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.68013205 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.67623685 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.66768561 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66474056 |
| 96 | Measles_Homo sapiens_hsa05162 | 0.66329416 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66127753 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65751019 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65467700 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65314736 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65132048 |
| 102 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62915122 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61914200 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61676800 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61356562 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60457894 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59023257 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57656488 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54719543 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54166410 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51109706 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.50997091 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50996589 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50111602 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48640550 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47782229 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46774405 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.46284738 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45713591 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44118962 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.43926026 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41963713 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41741146 |

